New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenance
Pflug, Natali, Cramer, Paula, Robrecht, Sandra, Bahlo, Jasmin, Westermann, Anne, Fink, Anna-Maria, Schrader, Alexandra, Mayer, Petra, Oberbeck, Sebastian, Seiler, Till, Zenz, Thorsten, Dürig, Jan, KreLangue:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2018.1488253
Date:
September, 2018
Fichier:
PDF, 1.04 MB
english, 2018